Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 38.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 640 shares of the biotechnology company’s stock after purchasing an additional 178 shares during the quarter. GAMMA Investing LLC’s holdings in Axon Enterprise were worth $188,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of AXON. Norges Bank acquired a new position in shares of Axon Enterprise during the 4th quarter worth $195,406,000. Motley Fool Asset Management LLC raised its position in Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock worth $153,981,000 after acquiring an additional 346,838 shares during the last quarter. 1832 Asset Management L.P. acquired a new stake in shares of Axon Enterprise in the first quarter valued at approximately $81,630,000. Vanguard Group Inc. increased its stake in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $39,907,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 44,000 shares of the company’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the sale, the president now directly owns 275,843 shares in the company, valued at approximately $85,500,296.28. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 43,668 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the transaction, the insider now directly owns 189,719 shares in the company, valued at $58,801,506.86. The disclosure for this sale can be found here. Insiders sold 89,447 shares of company stock valued at $27,684,677 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 3.5 %

Shares of Axon Enterprise stock traded up $10.02 during trading hours on Tuesday, reaching $296.18. The stock had a trading volume of 379,438 shares, compared to its average volume of 493,516. The firm has a market capitalization of $22.35 billion, a price-to-earnings ratio of 85.32, a P/E/G ratio of 6.59 and a beta of 0.95. Axon Enterprise, Inc. has a 1 year low of $175.59 and a 1 year high of $329.87. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. The firm has a 50 day simple moving average of $296.01 and a two-hundred day simple moving average of $294.35.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. During the same quarter last year, the firm posted $0.51 earnings per share. Axon Enterprise’s revenue for the quarter was up 34.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AXON. Jefferies Financial Group initiated coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price on the stock. Barclays lifted their price objective on Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 8th. Craig Hallum upped their target price on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. JMP Securities reaffirmed a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a research note on Tuesday, May 7th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $342.54.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.